Upload Avatar (500 x 500)
Wanjun Ding
Medical School
Wuhan University
Hubei
Language: English, Chinese
Molecular Diagnosis
Non-Invasive
Malignant Tumors
Early Detection
Breast Cancer
Lymphoma
Clinical Research
Basic Research
Oncology
Tumor Markers
Areas of Focus
- Early non-invasive molecular diagnosis of malignant tumors
- Basic and clinical research on breast cancer and lymphoma
Work Experience
- 2011.07-2014.11 Attending Physician, Oncology Center, Renmin Hospital, Wuhan University
- 2018.12-2022.11 Associate Chief Physician, Oncology Center, Renmin Hospital, Wuhan University
- 2022.12-present Chief Physician, Oncology Center, Renmin Hospital, Wuhan University
Academic Background & Achievements
- 1998.09-2003.06 Bachelor's Degree: Tongji Medical College, Huazhong University of Science and Technology
- 2005.09-2011.06 Master's and PhD in Surgery: Wuhan University First Clinical College
- 2019.01-2020.01 Visiting Scholar: Johns Hopkins University School of Medicine, Cancer Research Center
Publications
- Selective ERK inhibitor ulixertinib inhibits proliferation and induces apoptosis in lymphoma cell lines, Wan-Jun Ding, Wei-Ping Tao, Tao Zeng, et al., 2016
- Genes with mutation significance were highly associated with the clinical pattern of patients with breast cancer, Wan-Jun Ding, Tao Zeng, Li-Jun Wang, et al., 2017
- Effect of lenalidomide on the human gastric cancer cell line SGC7901/vincristine Notch Signaling, Wanjun Ding, Tao Zeng, Weiping Tao, et al., 2018
- Methylated markers accurately distinguish primary central nervous system lymphomas(PCNSL) from other CNS tumors, Bradley M. Downs, Wanjun Ding, et al., 2021
- Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer—a preclinical study, Guannan Wang, Alok Kumar, Wanjun Ding, et al., 2022
Awards
- 2014: Third Prize, Hubei Province Science and Technology Progress Award
